possible before ablation. The volume of alcohol to be administered is 25% to 50% of the aspirated volume, instilled over 15 to 30 minutes. Any fluid remaining in the cyst may reduce the effectiveness of the sclerosing therapy by diluting the alcohol, which may be why our patient had a symptomatic recurrence after the attempt at alcohol ablation. N-butyl cyanoacrylate (Histoacryl-Blue; Braun, Melsungen, Germany) has been used for embolization of vascular lesions and occlusion of fistulas, as well as a sclerosing agent for ablation of renal cysts. Cyanoacrylate glue immediately polymerizes into an adhesive solid adherent to tissue, with eventual fibrosis of whatever it is in contact with.
In conclusion, our case demonstrates that cyanoacrylate may succeed in sclerosing a hepatic cyst after alcohol has failed. Cyanoacrylate may be a reasonable alternative to ethanol for the treatment of symptomatic hepatic cysts. 
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Volume 17 Number 2 formed for obtaining specimens for histologic or cytologic examination of esophageal cancer. We report a patient who could not tolerate and refused the endoscopic procedure because his tooth broke on the first trial; a percutaneous computed tomography (CT)-guided biopsy was successfully performed and he was proven to have squamous-cell carcinoma of the esophagus.
A 63-year-old male patient was admitted to our institution with swallowing difficulty and weight loss of approximately 6 kg in the past 4 months. In the month before admission, his condition had deteriorated to the extent that he was able to tolerate only a liquid diet. He reported smoking one half pack of cigarettes and drinking 300 mL of red wine daily for 40 years and he had no history of esophageal disease. An upper gastrointestinal examination series suggested a cervical esophageal lesion, and he was referred to our hospital for further management.
A biopsy via rigid laryngoscopy was performed and revealed chronic inflammation. After obtaining clinical consultations and reviewing CT images, and considering the patient's refusal of further endoscopic procedures after a loose tooth broke on the first trial, a CT-guided percutaneous biopsy was arranged for tissue confirmation to facilitate further treatment planning. The patient received fluid via a venous route, supplemental oxygen via a nasal cannula, and pulse oximetry for monitoring blood oxygen saturation during the procedure. The biopsy was performed under CT guidance (Somatom Plus 4; Siemens, Erlangen, Germany) in supine position without moderate sedation. During CT scanning and needle advancement, the patient was instructed to hold his breath with persist inspiratory effort so the needle tip could approach the desired positions. Considering the 
